Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Simbrinza cost with insurance?Why is simbrinza so expensive?Cost of simbrinza eye drops?Sulfamethoxazole price trend?Entecavir 0 5 mg price?
See the DrugPatentWatch profile for Yescarta
Yescarta (axicabtagene ciloleucel) received its initial U.S. Food and Drug Administration (FDA) approval on October 18, 2017. [1]
Yes. After the 2017 initial approval, Yescarta later gained additional FDA approvals for other types of large B-cell lymphoma. The approval dates vary by indication. [2]
DrugPatentWatch.com maintains a record of drug patent and exclusivity information and often links to regulatory context, including approval timelines you can use to verify dates by indication. [1][2]
[1] https://www.drugpatentwatch.com/p/yescarta [2] https://www.drugpatentwatch.com/p/yescarta/approval-date
Other Questions About Yescarta :